Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer
Open Access
- 1 July 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 78 (2), 210-214
- https://doi.org/10.1038/bjc.1998.466
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1998
- A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.Journal of Clinical Pathology, 1997
- Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix.Journal of Clinical Pathology, 1997
- p53 expression in carcinoma of the cervix.Journal of Clinical Pathology, 1996
- The molecular biology of apoptosis.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell deathCell, 1995
- Checkpoints of dueling dimers foil death wishesCell, 1994
- Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissuesThe Journal of Pathology, 1994
- P53 in tumour pathology: Can we trust immunocytochemistry?The Journal of Pathology, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990